Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently trading near its ...

Truist Financial analyst Richard Newitter maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of ...

Truist Financial analyst Jasper Bibb maintained a Buy rating on Universal Technical Institute (UTI – Research Report) today and set a price ...

DAVENPORT & Co LLC lifted its stake in Direxion NASDAQ-100 Equal Weighted Index Shares (NASDAQ:QQQE – Free Report) by 9.9% during the 4th quarter, HoldingsChannel reports. The fund owned 14,983 shares ...

Greenleaf Trust increased its holdings in Equity Residential (NYSE:EQR – Free Report) by 7.4% in the fourth quarter, ...

Truist Securities adjusted its price target for Alphabet stock (NASDAQ:GOOGL), reducing it to $220 from the previous $225, ...

International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst ... Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes ...

Shares of Truist Financial Corp. TFC shed 1.84% to $47.01 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.61% to ...

In terms of financial projections, the company's ... rating and revised price target reflect a confidence in Truist's ability to execute its strategic initiatives and deliver value to shareholders.

William Rogers; Chairman of the Board, Chief Executive Officer; Truist Financial Corp Michael Maguire ... repurchase of $1 billion of our common stock. The execution of these important strategic ...